Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1294
Selected: 0
NCT IDTitle
NCT00153920Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma
NCT00116142Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
NCT03436654Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
NCT05349227Comprehensive Outcomes for After Cancer Health
NCT07130786Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
NCT02787369ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL
NCT02784366GI Complications in Cancer Immunotherapy Patients
NCT02375555Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
NCT04708860Feasibility of Fasting & Exercise in Pts With HR+ MBC
NCT06677190Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
NCT00165152Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
NCT04033497Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NCT06038318Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer
NCT01200238STA-9090(Ganetespib) in Metastatic Ocular Melanoma
NCT00476476Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
NCT03122717Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
NCT03392090SHARE (Sharing Goals and Preferences) Study
NCT00470847Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
NCT03709758Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
NCT00426205GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
NCT01243619FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
NCT03689595Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
NCT03294694Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
NCT00095875Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)
NCT04812795Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
NCT00809367Collection and Banking of Leukemia Cells MDS/AML
NCT00402545C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT03858712EHR-embedded OCDT in Breast or GI Cancer
NCT02916771Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
NCT00165087Treatment of Childhood Acute Lymphoblastic Leukemia
NCT00455624Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT04636710Refining Local-Regional Therapy for IBC
NCT00021996Valdecoxib in Treating Chronic Pain in Cancer Patients
NCT00895661High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
NCT00005627Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT05700461Drug Screening Using Novel IMD in Renal Cell Carcinoma
NCT00181688Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer
NCT06303713LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
NCT00165308Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
NCT01323920Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
NCT00148668Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
NCT01184326Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer
NCT02724878Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
NCT02279004A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
NCT03051672Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
NCT01523977Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
NCT04160065Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
NCT05327465Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NCT01647607Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
NCT02176031Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD